Production of Eicosanoids and Other Oxylipins by Pathogenic Eukaryotic Microbes

Clinical Microbiology Reviews - Tập 16 Số 3 - Trang 517-533 - 2003
Mairi C. Noverr1, John R. Erb‐Downward2,1, Gary B. Huffnagle2,1
1Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine
2Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, Michigan 48109-0642

Tóm tắt

SUMMARYOxylipins are oxygenated metabolites of fatty acids. Eicosanoids are a subset of oxylipins and include the prostaglandins and leukotrienes, which are potent regulators of host immune responses. Host cells are one source of eicosanoids and oxylipins during infection; however, another potential source of eicosanoids is the pathogen itself. A broad range of pathogenic fungi, protozoa, and helminths produce eicosanoids and other oxylipins by novel synthesis pathways. Why do these organisms produce oxylipins? Accumulating data suggest that phase change and differentiation in these organisms are controlled by oxylipins, including prostaglandins and lipoxygenase products. The precise role of pathogen-derived eicosanoids in pathogenesis remains to be determined, but the potential link between pathogen eicosanoids and the development of TH2 responses in the host is intriguing. Mammalian prostaglandins and leukotrienes have been studied extensively, and these molecules can modulate Th1 versus Th2 immune responses, chemokine production, phagocytosis, lymphocyte proliferation, and leukocyte chemotaxis. Thus, eicosanoids and oxylipins (host or microbe) may be mediators of a direct host-pathogen “cross-talk” that promotes chronic infection and hypersensitivity disease, common features of infection by eukaryotic pathogens.

Từ khóa


Tài liệu tham khảo

10.1016/0166-6851(95)00085-F

10.1016/S0020-7519(99)00020-X

10.1084/jem.20021183

Aliberti, J., and A. Sher. 2001. Positive and negative regulation of pathogen induced dendritic cell function by G-protein coupled receptors. Mol. Immunol.38:891-893.

10.1016/S1286-4579(02)01618-0

10.1084/jem.193.10.1135

Bailie, M. B., T. J. Standiford, L. L. Laichalk, M. J. Coffey, R. Strieter, and M. Peters-Golden. 1996. Leukotriene-deficient mice manifest enhanced lethality from Klebsiella pneumoniae in association with decreased alveolar macrophage phagocytic and bactericidal activities. J. Immunol.157:5221-5224.

Reference deleted.

10.1016/S0092-8674(02)00749-3

Bavaresco, L., C. Fregoni, E. Cantu, and M. Trevisan. 1999. Stilbene compounds: from the grapevine to wine. Drugs Exp. Clin. Res.25:57-63.

Betz, M., and B. S. Fox. 1991. Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines. J. Immunol.146:108-113.

10.1093/infdis/165.5.898

10.1016/S0723-2020(11)80153-0

Botha, A., J. Kock, and S. Nigam. 1998. The production of eicosanoid precursors by mucoralean fungi. Adv. Exp. Med. Biol.433:227-229.

10.1023/A:1001848709005

10.1016/S0021-9258(18)42102-3

10.1164/ajrccm.157.1.9702074

Casadevall A. and J. R. Perfect. 1998. Cryptococcus neoformans . ASM Press Washington D.C.

10.1007/BF01487749

10.1128/iai.62.8.3138-3145.1994

10.4269/ajtmh.1993.48.645

10.1128/iai.64.4.1181-1189.1996

10.1093/infdis/175.2.414

10.1042/bj3470431

Coetzee, D., J. Kock, A. Botha, M. van Dyk, E. Smit, P. Botes, and O. Augustyn. 1991. Yeast eicosanoids III. The distribution of arachidonic acid metabolites in the life-cycle of Dipodascopsis uninucleata. Syst. Appl. Microbiol.15:311-318.

10.1016/0006-291X(84)90766-6

10.1007/s004360050138

10.1006/expr.1995.1151

10.1016/S0020-7519(97)00153-7

10.1046/j.1365-2958.2000.02213.x

10.1046/j.1365-3024.1999.00211.x

10.1002/eji.1830271254

10.1074/jbc.M006712200

10.1111/j.1574-6968.2001.tb10616.x

10.1016/S1388-1981(00)00073-1

10.1038/35081178

Djurkovic-Djakovic, O. 1998. Toxoplasmosis and immunosuppression. Srp. Arkh. Tselok. Lek.126:197-203.

Farrell, J. P., and C. E. Kirkpatrick. 1987. Experimental cutaneous leishmaniasis. II. A possible role for prostaglandins in exacerbation of disease in Leishmania major-infected BALB/c mice. J. Immunol.138:902-907.

Fierer, J., J. A. Salmon, and B. A. Askonas. 1984. African trypanosomiasis alters prostaglandin production by murine peritoneal macrophages. Clin. Exp. Immunol.58:548-556.

Ford-Hutchinson, A. W. 1990. Leukotriene B4 in inflammation. Crit. Rev. Immunol.10:1-12.

10.1007/BF00932504

10.1126/science.294.5548.1871

10.2307/3281679

10.1016/0014-4894(85)90055-4

10.1016/0014-4894(87)90137-8

10.2307/3284657

Gasperini, S., L. Crepaldi, F. Calzetti, L. Gatto, C. Berlato, F. Bazzoni, A. Yoshimura, and M. A. Cassatella. 2002. Interleukin-10 and cAMP-elevating agents cooperate to induce suppressor of cytokine signaling-3 via a protein kinase A-independent signal. Eur. Cytokine Netw.13:47-53.

10.1073/pnas.90.13.6115

10.1128/CMR.13.1.122

10.1007/s004360050250

10.1128/iai.62.7.2908-2916.1994

10.1093/oxfordjournals.jbchem.a003165

10.1098/rstb.2000.0564

10.1017/S0031182000074503

10.1021/bi00138a016

Herman R. P. 1998. Oxylipin production and action in fungi and related organisms p. 115-132. In A. F. Rowley H. Kuhn and T. Schewe (ed.) Eicosanoids and related compounds in plants and animals. Princeton Unversity Press Princeton N.J.

10.1016/0090-6980(85)90140-6

10.1128/AEM.67.7.2982-2992.2001

10.1074/jbc.274.40.28219

10.1016/S1383-5769(01)00077-0

Jonsson E. W. and S. Dahlen. 1999. The role of eicosanoids in inflammation and allergy p. 233-272. In F. Marks and G. Furstenberger (ed.) Prostaglandins leukotrienes and other eicosanoids. Wiley-VCH Weinheim Germany.

10.1016/0014-4894(92)90175-A

10.1128/iai.58.1.260-262.1990

10.1016/0262-1746(86)90182-4

10.1007/BF02524293

10.1016/0147-5975(84)90004-5

Kock, J., D. Coetzee, M. van Dyk, M. Truscott, P. Cloete, V. van Wyk, and O. Augustyn. 1991. Evidence for pharmacologically active prostaglandins in yeasts. S. Afr. J. Sci.87:73-76.

10.1023/A:1012200119681

10.1023/A:1001869410323

10.1023/A:1002735216303

10.1006/expr.1995.1097

10.1084/jem.192.9.1327

10.1084/jem.188.6.1197

10.1084/jem.20020885

10.1074/jbc.274.49.34683

10.1021/bi011348p

10.1016/S0021-9258(18)60727-6

Kwon-Chung K. J. 1992. Medical mycology. Lea & Febiger Philadelphia Pa.

10.1046/j.1472-765X.1998.00324.x

10.7326/0003-4819-111-2-125

10.4269/ajtmh.1992.46.520

10.1172/JCI115691

Lodewyk, J., J. Kock, P. Venter, A. Botha, D. Coetzee, P. Botes, and S. Nigam. 1998. The production of biologically active eicosanoids by yeasts. Adv. Exp. Med. Biol.433:217-219.

10.1128/IAI.68.11.6355-6361.2000

10.1016/S0047-6374(01)00322-0

10.1128/IAI.69.4.2011-2016.2001

10.1165/ajrcmb.23.6.4246

10.1128/IAI.66.11.5140-5146.1998

Mandell G. L. J. E. Bennett and R. Dolin (ed.). 1995. Mandell Douglas and Bennett's principles and practice of infectious diseases 4th ed. Churchill Livingstone New York N.Y.

Marks F. 1999. Arachidonic acid and companions: an abundant source of biological signals p. 1-46. In F. Marks and G. Furstenberger (ed.) Prostaglandins leukotrienes and other eicosanoids. Wiley-VCH Weinheim Germany.

10.1126/science.287.5460.2013

10.1016/S1471-4906(02)02288-3

10.1042/bj3130223

Meyer, F., H. Meyer, and E. Bueding. 1970. Lipid Metabolism in the parasitic and free-living worms Schistosoma mansoni and Dugesia dorotocephala. Biochim. Biophys. Acta210:256-266.

10.1182/blood.V98.6.1942

10.1016/0006-2952(95)02072-1

10.1006/pupt.2000.0262

10.1128/IAI.71.3.1538-1547.2003

10.1128/IAI.69.5.2957-2963.2001

10.1128/IAI.70.1.400-402.2002

10.1002/cbf.290070205

10.1016/S0091-6749(99)70127-2

Pearce, E. J., and A. J. Macdonald. 2002. The immunobiology of schistosomiasis. Nature2:499-511.

10.1016/0035-9203(90)90085-S

10.1038/nm0902-931

Peters-Golden, M. 1997. Lipid mediator synthesis by lung macrophages. Lung Biol. Health Dis.102:151-182.

10.1164/ajrccm.165.8.2202071c

10.1006/cimm.1999.1463

10.1006/bbrc.1998.9853

Raible, D. G., E. S. Schulman, J. DiMuzio, R. Cardillo, and T. J. Post. 1992. Mast cell mediators prostaglandin-D2 and histamine activate human eosinophils. J. Immunol.148:3536-3542.

10.1128/AEM.68.11.5459-5463.2002

10.4049/jimmunol.165.8.4567

10.1146/annurev.iy.13.040195.001055

10.1038/34178

10.1111/j.1749-6632.1994.tb52741.x

10.1128/iai.59.4.1442-1447.1991

Rowley A. F. H. Kuhn and T. Schewe. 1998. Enzymes and factors involved in the biosynthesis of eicosanoids. Princeton University Press Princeton N.J.

10.1038/nri933

10.1111/j.1550-7408.1991.tb04816.x

10.1016/S0014-4894(85)80024-2

10.2307/3281745

10.2307/3281410

Schewe T. 1998. Basic function of lipoxygenases and their products in higher plants p. 133-150. In A. F. Rowley H. Kuhn and T. Schewe (ed.) Eicosanoids and related compounds in plants and animals. Princeton University Press Princeton N.J.

10.1074/jbc.M202998200

10.1023/A:1013089817318

10.1016/S0014-5793(97)01388-4

10.1016/0020-711X(83)90019-8

10.1016/S0006-2952(01)00586-X

10.1080/14756360109162392

10.1006/expr.2000.4531

10.1645/0022-3395(2001)087[0242:IOTLPB]2.0.CO;2

Snijdewint, F. G., P. Kalinski, E. A. Wierenga, J. D. Bos, and M. L. Kapsenberg. 1993. Prostaglandin E2 differentially modulates cytokine secretion profiles of human T helper lymphocytes. J. Immunol.150:5321-5329.

10.1016/S0009-9120(96)00155-5

10.1165/ajrcmb/6.1.75

Stanley D. W. and J. S. Miller. 1998. Eicosanoids in animal reproduction: what can we learn from invertebrates? p. 183-196. In A. F. Rowley H. Kuhn and T. Schewe (ed.) Eicosanoids and related compounds in plants and animals. Princeton University Press Princeton N.J.

10.1084/jem.180.6.2365

10.1074/jbc.M001408200

10.1002/eji.1830150820

10.1007/s004360050676

10.1128/iai.61.4.1432-1441.1993

10.1016/S0140-6736(98)10364-1

10.1016/0014-5793(91)80586-R

Vane, J. R., and R. M. Botting. 1998. Mechanism of action of antiinflammatory cells. Lung Biol. Health Dis.114:1-24.

10.1016/0306-3623(83)90053-8

Warburg, O., and W. Christian. 1933. Über das Gelbe Ferment und Seine Wirkungen. Biochem. Z.266:377-411.

10.1021/jm0201262

10.1016/S0171-2985(99)80064-3

10.1084/jem.173.1.65

10.1084/jem.180.5.1637

10.2307/3283384

10.1242/jeb.204.23.4157